Innovative biomarkers for predicting type 2 diabetes mellitus: relevance to dietary management of frailty in older adults

[1]  M. Weickert,et al.  Impact of Diet Composition on Blood Glucose Regulation , 2016, Critical reviews in food science and nutrition.

[2]  D. Thompson,et al.  Elevated plasma pigment epithelium‐derived factor in children with type 2 diabetes mellitus is attributable to obesity , 2015, Pediatric diabetes.

[3]  S. Mori,et al.  Risk factors associated with falls in elderly patients with type 2 diabetes. , 2015, Journal of diabetes and its complications.

[4]  L. Donini,et al.  Effects of a vitamin D and leucine-enriched whey protein nutritional supplement on measures of sarcopenia in older adults, the PROVIDE study: a randomized, double-blind, placebo-controlled trial. , 2015, Journal of the American Medical Directors Association.

[5]  Chung-Yi Li,et al.  Association Between History of Severe Hypoglycemia and Risk of Falls in Younger and Older Patients With Diabetes , 2015, Medicine.

[6]  L. D. de Groot,et al.  MECHANISMS IN ENDOCRINOLOGY: Exogenous insulin does not increase muscle protein synthesis rate when administered systemically: a systematic review. , 2015, European journal of endocrinology.

[7]  L. Larsson,et al.  Oxidative proteome alterations during skeletal muscle ageing , 2015, Redox biology.

[8]  S. Perera,et al.  Efficacy and safety of single-dose zoledronic acid for osteoporosis in frail elderly women: a randomized clinical trial. , 2015, JAMA internal medicine.

[9]  J. Tombran-Tink,et al.  Pigment Epithelium Derived Factor Suppresses Expression of Sost/Sclerostin by Osteocytes: Implication for Its Role in Bone Matrix Mineralization , 2015, Journal of cellular physiology.

[10]  A. Lubkowska,et al.  Relationship between the Concentrations of Heavy Metals and Bioelements in Aging Men with Metabolic Syndrome , 2015, International journal of environmental research and public health.

[11]  A. Sinclair,et al.  Diabetes in older people: new insights and remaining challenges. , 2015, The lancet. Diabetes & endocrinology.

[12]  H. Griffiths,et al.  Ageing, adipose tissue, fatty acids and inflammation , 2015, Biogerontology.

[13]  L. D. de Groot,et al.  Micronutrient intakes and potential inadequacies of community-dwelling older adults: a systematic review , 2015, British Journal of Nutrition.

[14]  Jian-xing Ma,et al.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases , 2015, Clinical science.

[15]  Pingping Li,et al.  Elevated circulating VE-cadherin+CD144+endothelial microparticles in ischemic cerebrovascular disease. , 2015, Thrombosis research.

[16]  H. Cengiz,et al.  Prophylactic vitamin D supplementation in ovarian hyperstimulation syndrome: an animal study , 2015, Archives of Gynecology and Obstetrics.

[17]  Jun Yu,et al.  Unconjugated Bilirubin Mediates Heme Oxygenase-1–Induced Vascular Benefits in Diabetic Mice , 2014, Diabetes.

[18]  T. Raghunathan,et al.  Total Serum Bilirubin Predicts Fat-Soluble Vitamin Deficiency Better Than Serum Bile Acids in Infants With Biliary Atresia , 2014, Journal of pediatric gastroenterology and nutrition.

[19]  K. Nair,et al.  Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. , 2014, Clinical nutrition.

[20]  C. Terwee,et al.  Determinants of protein–energy malnutrition in community-dwelling older adults: A systematic review of observational studies , 2014, Ageing Research Reviews.

[21]  A. Avogaro,et al.  The Effects of Dipeptidyl Peptidase-4 Inhibition on Microvascular Diabetes Complications , 2014, Diabetes Care.

[22]  C. Jung,et al.  Serum bilirubin as a predictor of incident metabolic syndrome: a 4-year retrospective longitudinal study of 6205 initially healthy Korean men. , 2014, Diabetes & metabolism.

[23]  S. Muurinen,et al.  Dentition status, malnutrition and mortality among older service housing residents , 2014, The journal of nutrition, health & aging.

[24]  C. Geisler,et al.  Assessment and definition of lean body mass deficiency in the elderly , 2014, European Journal of Clinical Nutrition.

[25]  B. Wolffenbuttel,et al.  The inverse association of incident cardiovascular disease with plasma bilirubin is unaffected by adiponectin. , 2014, Atherosclerosis.

[26]  D. Knol,et al.  Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial. , 2014, The American journal of clinical nutrition.

[27]  M. Woodward,et al.  Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes , 2014, The Lancet.

[28]  L. Belo,et al.  Body Fat Percentage Is a Major Determinant of Total Bilirubin Independently of UGT1A1*28 Polymorphism in Young Obese , 2014, PloS one.

[29]  A. Jenkins,et al.  Clinical correlates of serum pigment epithelium-derived factor in type 2 diabetes patients. , 2014, Journal of diabetes and its complications.

[30]  P. Kruzliak,et al.  Effects of serum bilirubin on atherosclerotic processes , 2014, Annals of medicine.

[31]  J. Goff,et al.  Human UGT1A4 and UGT1A3 conjugate 25-hydroxyvitamin D3: metabolite structure, kinetics, inducibility, and interindividual variability. , 2014, Endocrinology.

[32]  M. Barbagallo,et al.  The Interplay between Magnesium and Testosterone in Modulating Physical Function in Men , 2014, International journal of endocrinology.

[33]  C. Tiribelli,et al.  Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. , 2014, Cellular signalling.

[34]  A. McTiernan,et al.  Effect of a 12-Month Exercise Intervention on Serum Biomarkers of Angiogenesis in Postmenopausal Women: A Randomized Controlled Trial , 2014, Cancer Epidemiology, Biomarkers & Prevention.

[35]  H. Randeva,et al.  Plasma irisin levels predict telomere length in healthy adults , 2014, AGE.

[36]  M. Saltzman,et al.  Pigment epithelium-derived factor (PEDF) suppresses IL-1β-mediated c-Jun N-terminal kinase (JNK) activation to improve hepatocyte insulin signaling. , 2014, Endocrinology.

[37]  Qifu Li,et al.  Rosiglitazone inhibits expression and secretion of PEDF in adipose tissue and liver of male SD rats via a PPAR-γ independent mechanism. , 2014, Endocrinology.

[38]  L. Otterbein,et al.  Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation. , 2014, Endocrinology.

[39]  H. Deng,et al.  PEDF Expression Is Inhibited by Insulin Treatment in Adipose Tissue via Suppressing 11β-HSD1 , 2013, PloS one.

[40]  J. Tombran-Tink,et al.  Pigment Epithelium‐Derived Factor Enhances Differentiation and Mineral Deposition of Human Mesenchymal Stem Cells , 2013, Stem cells.

[41]  J. Watchko,et al.  Bilirubin-induced neurologic damage--mechanisms and management approaches. , 2013, The New England journal of medicine.

[42]  G. Butler-Browne,et al.  Label-free Quantitative Protein Profiling of vastus lateralis Muscle During Human Aging* , 2013, Molecular & Cellular Proteomics.

[43]  Keith Smolkowski,et al.  Essential amino acid supplementation in patients following total knee arthroplasty. , 2013, The Journal of clinical investigation.

[44]  A. Zittermann.  Magnesium deficit ? overlooked cause of low vitamin D status? , 2013, BMC Medicine.

[45]  Maarten Hulsmans,et al.  MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. , 2013, Cardiovascular research.

[46]  E. Dall’aglio,et al.  IGF-1, the Cross Road of the Nutritional, Inflammatory and Hormonal Pathways to Frailty , 2013, Nutrients.

[47]  V. Samuel,et al.  Determination of mesenchymal stem cell fate by pigment epithelium‐derived factor (PEDF) results in increased adiposity and reduced bone mineral content , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[48]  M. Rickels,et al.  Personalized cytomic assessment of vascular health: Evaluation of the vascular health profile in diabetes mellitus , 2013, Cytometry. Part B, Clinical cytometry.

[49]  T. Clemens,et al.  A Mouse Model for Human Osteogenesis Imperfecta Type VI , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[50]  S. Cummings,et al.  Effects of antiresorptive therapies on glucose metabolism: Results from the FIT, HORIZON‐PFT, and FREEDOM trials , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[51]  A. Musarò,et al.  Signalling pathways regulating muscle mass in ageing skeletal muscle. The role of the IGF1-Akt-mTOR-FoxO pathway , 2013, Biogerontology.

[52]  J. Eckel,et al.  Identification and Validation of Novel Contraction-Regulated Myokines Released from Primary Human Skeletal Muscle Cells , 2013, PloS one.

[53]  A. Bulmer,et al.  Bilirubin and beyond: a review of lipid status in Gilbert's syndrome and its relevance to cardiovascular disease protection. , 2013, Progress in lipid research.

[54]  C. ffrench-Constant,et al.  Unconjugated Bilirubin Restricts Oligodendrocyte Differentiation and Axonal Myelination , 2013, Molecular Neurobiology.

[55]  V. Notario,et al.  The effects of PEDF on cancer biology: mechanisms of action and therapeutic potential , 2013, Nature Reviews Cancer.

[56]  Stuart M Phillips,et al.  Interactions between exercise and nutrition to prevent muscle waste during ageing. , 2013, British journal of clinical pharmacology.

[57]  R. Thorne,et al.  The origin of circulating CD36 in type 2 diabetes , 2013, Nutrition & Diabetes.

[58]  A. Bulmer,et al.  Extracellular and intracellular anti-mutagenic effects of bile pigments in the Salmonella typhimurium reverse mutation assay , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[59]  R. Dullaart,et al.  Lower carotid intima media thickness is predicted by higher serum bilirubin in both non-diabetic and Type 2 diabetic subjects. , 2012, Clinica chimica acta; international journal of clinical chemistry.

[60]  H. Teede,et al.  Pigment Epithelium‐Derived Factor, Insulin Sensitivity, and Adiposity in Polycystic Ovary Syndrome: Impact of Exercise Training , 2012, Obesity.

[61]  M. Hedayati,et al.  The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial , 2012, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences.

[62]  B. Frier,et al.  Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs , 2012, Diabetes, obesity & metabolism.

[63]  T. Kao,et al.  Associations between serum total bilirubin levels and functional dependence in the elderly , 2012, Internal medicine journal.

[64]  A. Bulmer,et al.  Effects of unconjugated bilirubin on chromosomal damage in individuals with Gilbert's syndrome measured with the micronucleus cytome assay. , 2012, Mutagenesis.

[65]  V. Pavlov,et al.  Identification of Pigment Epithelium-Derived Factor as an Adipocyte-Derived Inflammatory Factor , 2012, Molecular medicine.

[66]  Young Seol Kim,et al.  C1q/TNF-Related Protein-3 (CTRP-3) and Pigment Epithelium-Derived Factor (PEDF) Concentrations in Patients With Type 2 Diabetes and Metabolic Syndrome , 2012, Diabetes.

[67]  D. Thompson,et al.  Pigment epithelium-derived factor (PEDF) varies with body composition and insulin resistance in healthy young people. , 2012, The Journal of clinical endocrinology and metabolism.

[68]  H. Griffiths,et al.  Palmitate promotes monocyte atherogenicity via de novo ceramide synthesis. , 2012, Free radical biology & medicine.

[69]  Yu Luo,et al.  Plasma Endothelial Microparticles and Their Correlation With the Presence of Hypertension and Arterial Stiffness in Patients With Type 2 Diabetes , 2012, Journal of clinical hypertension.

[70]  C. Conner,et al.  Association between hypoglycaemic events and fall‐related fractures in Medicare‐covered patients with type 2 diabetes , 2012, Diabetes, obesity & metabolism.

[71]  S. Baindur-Hudson,et al.  The Emerging Role of PEDF in Stem Cell Biology , 2012, Journal of biomedicine & biotechnology.

[72]  L. Vítek.  The Role of Bilirubin in Diabetes, Metabolic Syndrome, and Cardiovascular Diseases , 2012, Front. Pharmacol..

[73]  K. Williams,et al.  Microvesicles: potential markers and mediators of endothelial dysfunction , 2012, Current opinion in endocrinology, diabetes, and obesity.

[74]  B. Cookson,et al.  Membrane Vesicle Release in Bacteria, Eukaryotes, and Archaea: a Conserved yet Underappreciated Aspect of Microbial Life , 2012, Infection and Immunity.

[75]  G. Guan,et al.  Dipeptidyl peptidase-IV is a potential molecular biomarker in diabetic kidney disease , 2012, Diabetes & vascular disease research.

[76]  A. Boner,et al.  Lack of expression of SERPINF1, the gene coding for pigment epithelium‐derived factor, causes progressively deforming osteogenesis imperfecta with normal type I collagen , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[77]  P. Bregestovski,et al.  Excitatory GABA: How a Correct Observation May Turn Out to be an Experimental Artifact , 2012, Front. Pharmacol..

[78]  T. Imaizumi,et al.  Serum level of pigment epithelium-derived factor is a marker of atherosclerosis in humans. , 2011, Atherosclerosis.

[79]  H. Tilg,et al.  Effect of weight loss on serum pigment epithelium‐derived factor levels , 2011, European journal of clinical investigation.

[80]  Peter Kovacs,et al.  Combined proteomic and metabolomic profiling of serum reveals association of the complement system with obesity and identifies novel markers of body fat mass changes. , 2011, Journal of proteome research.

[81]  G. Nickenig,et al.  Circulating CD31+/Annexin V+ microparticles correlate with cardiovascular outcomes. , 2011, European heart journal.

[82]  Jie-Jin Wang,et al.  High serum bilirubin levels and diabetic retinopathy: the Hisayama Study. , 2011, Ophthalmology.

[83]  P. Meikle,et al.  Pigment Epithelium–Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase , 2011, Diabetes.

[84]  Cheng Zhang,et al.  Circulating endothelial progenitor cells and cellular membrane microparticles in db/db diabetic mouse: possible implications in cerebral ischemic damage. , 2011, American journal of physiology. Endocrinology and metabolism.

[85]  J. Roh,et al.  Risk of Macrovascular Complications in Type 2 Diabetes Mellitus: Endothelial Microparticle Profiles , 2011, Cerebrovascular Diseases.

[86]  A. Hoischen,et al.  Exome sequencing identifies truncating mutations in human SERPINF1 in autosomal-recessive osteogenesis imperfecta. , 2011, American journal of human genetics.

[87]  P. Halban,et al.  Bimodal Effect on Pancreatic β-Cells of Secretory Products From Normal or Insulin-Resistant Human Skeletal Muscle , 2011, Diabetes.

[88]  S. Yamagishi,et al.  Advanced glycation end products (AGEs), oxidative stress and diabetic retinopathy. , 2011, Current pharmaceutical biotechnology.

[89]  Qifu Li,et al.  Serum pigment epithelium-derived factor is elevated in women with polycystic ovary syndrome and correlates with insulin resistance. , 2011, The Journal of clinical endocrinology and metabolism.

[90]  V. Basevi.  Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.

[91]  D. Chae,et al.  Hyperbilirubinemia reduces the streptozotocin-induced pancreatic damage through attenuating the oxidative stress in the Gunn rat. , 2010, The Tohoku journal of experimental medicine.

[92]  B. Payrastre,et al.  Internalization of microparticles by endothelial cells promotes platelet/endothelial cell interaction under flow , 2010, Journal of thrombosis and haemostasis : JTH.

[93]  E. Janus,et al.  Plasma level of pigment epithelium-derived factor is independently associated with the development of the metabolic syndrome in Chinese men: a 10-year prospective study. , 2010, The Journal of clinical endocrinology and metabolism.

[94]  R. Takayanagi,et al.  Bilirubin and biliverdin protect rodents against diabetic nephropathy by downregulating NAD(P)H oxidase. , 2010, Kidney international.

[95]  Kristina M. Little,et al.  The plasma microparticle proteome. , 2010, Seminars in thrombosis and hemostasis.

[96]  L. Peng,et al.  Care of elderly patients with diabetes mellitus: A focus on frailty , 2010, Ageing Research Reviews.

[97]  J. Moreno-Navarrete,et al.  Circulating pigment epithelium-derived factor levels are associated with insulin resistance and decrease after weight loss. , 2010, The Journal of clinical endocrinology and metabolism.

[98]  H. Xiang,et al.  [Influences of hypertension and diabetes on arterial compliances and endothelial microparticle level]. , 2010, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[99]  T. Imaizumi,et al.  Serum levels of pigment epithelium-derived factor (PEDF) are an independent determinant of insulin resistance in patients with essential hypertension. , 2010, International journal of cardiology.

[100]  G. Paolisso,et al.  Frailty and muscle metabolism dysregulation in the elderly , 2010, Biogerontology.

[101]  G. Chertow,et al.  Vitamin D deficiency and frailty in older Americans , 2010, Journal of internal medicine.

[102]  E. Duh,et al.  Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression. , 2010, Investigative ophthalmology & visual science.

[103]  D. Chae,et al.  High serum bilirubin is associated with the reduced risk of diabetes mellitus and diabetic nephropathy. , 2010, The Tohoku journal of experimental medicine.

[104]  L. Notari,et al.  Pigment epithelium‐derived factor binds to cell‐surface F1‐ATP synthase , 2010, The FEBS journal.

[105]  W. Evans,et al.  Skeletal muscle loss: cachexia, sarcopenia, and inactivity. , 2010, The American journal of clinical nutrition.

[106]  Antonio Muscari,et al.  The involvement of circulating microparticles in inflammation, coagulation and cardiovascular diseases. , 2010, The Canadian journal of cardiology.

[107]  S. Jee,et al.  Low Serum Bilirubin Level as an Independent Predictor of Stroke Incidence: A Prospective Study in Korean Men and Women , 2009, Stroke.

[108]  Takanori Matsui,et al.  Protective role of pigment epithelium‐derived factor (PEDF) in early phase of experimental diabetic retinopathy , 2009, Diabetes/metabolism research and reviews.

[109]  J. Ostrow,et al.  Bilirubin chemistry and metabolism; harmful and protective aspects. , 2009, Current pharmaceutical design.

[110]  J. Ostrow,et al.  Bilirubin inhibits the TNFalpha-related induction of three endothelial adhesion molecules. , 2009, Biochemical and biophysical research communications.

[111]  C. Théry,et al.  Membrane vesicles as conveyors of immune responses , 2009, Nature Reviews Immunology.

[112]  Arya M. Sharma,et al.  Acute effect of weight loss on levels of total bilirubin in obese, cardiovascular high-risk patients: an analysis from the lead-in period of the Sibutramine Cardiovascular Outcome trial. , 2009, Metabolism: clinical and experimental.

[113]  H. Griffiths,et al.  Oleate protects against palmitate-induced insulin resistance in L6 myotubes , 2009, British Journal of Nutrition.

[114]  S. Fujita,et al.  Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism , 2009, Diabetologia.

[115]  D. James,et al.  Pigment epithelium-derived factor contributes to insulin resistance in obesity. , 2009, Cell metabolism.

[116]  W. Durante,et al.  Hypochlorous acid‐induced heme oxygenase‐1 gene expression promotes human endothelial cell survival , 2009, American journal of physiology. Cell physiology.

[117]  R. Kennedy,et al.  Characterization of PEDF: A multi‐functional serpin family protein , 2009, Journal of cellular biochemistry.

[118]  Didier Revel,et al.  Increased levels of endothelial microparticles CD144 (VE-Cadherin) positives in type 2 diabetic patients with coronary noncalcified plaques evaluated by multidetector computed tomography (MDCT). , 2009, Atherosclerosis.

[119]  S. Nomura,et al.  Correlation and association between plasma platelet-, monocyte- and endothelial cell-derived microparticles in hypertensive patients with type 2 diabetes mellitus , 2009, Platelets.

[120]  S. Yamagishi,et al.  Serum levels of pigment epithelium‐derived factor (PEDF) are positively associated with visceral adiposity in Japanese patients with type 2 diabetes , 2009, Diabetes/metabolism research and reviews.

[121]  N. Nakamura,et al.  Relationship between serum bilirubin and albuminuria in patients with type 2 diabetes. , 2008, Kidney international.

[122]  A. Jenkins,et al.  Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. , 2008, Diabetes research and clinical practice.

[123]  G. Leftheriotis,et al.  Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. , 2008, The American journal of pathology.

[124]  J. Weuve,et al.  Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004. , 2008, The American journal of medicine.

[125]  H. Kaneto,et al.  Increased serum pigment epithelium-derived factor levels in type 1 diabetic patients with diabetic retinopathy. , 2008, Diabetes research and clinical practice.

[126]  L. Horstman,et al.  Microparticle‐mediated thrombin generation assay: increased activity in patients with recurrent thrombosis , 2008, Journal of thrombosis and haemostasis : JTH.

[127]  M. Matsumura,et al.  Relationship between pigment epithelium-derived factor (PEDF) and renal function in patients with diabetic retinopathy , 2008, Molecular vision.

[128]  S. Crawford,et al.  Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL). , 2008, Journal of hepatology.

[129]  A. Tedgui,et al.  Microparticles and type 2 diabetes. , 2008, Diabetes & metabolism.

[130]  Minoru Satoh,et al.  Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy , 2008, Clinical and Experimental Nephrology.

[131]  M. Capogrossi,et al.  PEDF, PPAR-γ, p53: Deadly circuits arise when worlds collide , 2007 .

[132]  R. Takayanagi,et al.  Relationship between Gilbert syndrome and prevalence of vascular complications in patients with diabetes. , 2007, JAMA.

[133]  T. Hawn,et al.  Toll-Like Receptor-4 Mediates Vascular Inflammation and Insulin Resistance in Diet-Induced Obesity , 2007, Circulation research.

[134]  W. Jia,et al.  [Change and significance of serum pigment epithelium-derived factor in type 2 diabetic nephropathy]. , 2007, Zhonghua yi xue za zhi.

[135]  A. Piccin,et al.  Circulating microparticles: pathophysiology and clinical implications. , 2007, Blood reviews.

[136]  M. Matsumura,et al.  Plasma concentration of pigment epithelium-derived factor in patients with diabetic retinopathy. , 2007, The Journal of clinical endocrinology and metabolism.

[137]  R. Paltriccia,et al.  Increased Ratio of CD31+/CD42− Microparticles to Endothelial Progenitors as a Novel Marker of Atherosclerosis in Hypercholesterolemia , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[138]  J. Flier,et al.  TLR4 links innate immunity and fatty acid-induced insulin resistance. , 2006, The Journal of clinical investigation.

[139]  T. Imaizumi,et al.  Elevated serum levels of pigment epithelium-derived factor in the metabolic syndrome. , 2006, The Journal of clinical endocrinology and metabolism.

[140]  M. Sheffield-Moore,et al.  Skeletal muscle protein anabolic response to increased energy and insulin is preserved in poorly controlled type 2 diabetes. , 2006, The Journal of nutrition.

[141]  M. Matsumura,et al.  Elevation of monocyte-derived microparticles in patients with diabetic retinopathy. , 2006, Diabetes research and clinical practice.

[142]  L. Novotný,et al.  Decreased levels of advanced glycation end-products in patients with Gilbert syndrome. , 2005, Cellular and molecular biology.

[143]  I. McDowell,et al.  A global clinical measure of fitness and frailty in elderly people , 2005, Canadian Medical Association Journal.

[144]  T. Iwasaka,et al.  Benidipine improves oxidized LDL-dependent monocyte and endothelial dysfunction in hypertensive patients with type 2 diabetes mellitus , 2005, Journal of Human Hypertension.

[145]  Tomohiro Sakamoto,et al.  Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease. , 2005, Journal of the American College of Cardiology.

[146]  L. Vítek.  Impact of Serum Bilirubin on Human Diseases , 2005, Pediatrics.

[147]  M. Matsumura,et al.  Increased levels of platelet-derived microparticles in patients with diabetic retinopathy. , 2005, Diabetes research and clinical practice.

[148]  P. Choong,et al.  Localization of Pigment Epithelium-Derived Factor in Growing Mouse Bone , 2005, Calcified Tissue International.

[149]  T. Kodama,et al.  Bilirubin From Heme Oxygenase-1 Attenuates Vascular Endothelial Activation and Dysfunction , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[150]  A. Goldberg,et al.  IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. , 2004, American journal of physiology. Endocrinology and metabolism.

[151]  C. Barnstable,et al.  Osteoblasts and osteoclasts express PEDF, VEGF-A isoforms, and VEGF receptors: possible mediators of angiogenesis and matrix remodeling in the bone. , 2004, Biochemical and biophysical research communications.

[152]  Toshiji Iwasaka,et al.  Effects of Losartan and Simvastatin on Monocyte-Derived Microparticles in Hypertensive Patients With and Without Type 2 Diabetes Mellitus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[153]  T. Iwasaka,et al.  Effect of Ticlopidine on Monocyte-derived Microparticles and Activated Platelet Markers in Diabetes Mellitus , 2004, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

[154]  R. Andriantsitohaina,et al.  Shed Membrane Particles From T Lymphocytes Impair Endothelial Function and Regulate Endothelial Protein Expression , 2004, Circulation.

[155]  T. Sugiyama,et al.  Induction of heme oxygenase-1 in monocytes suppresses angiotensin II-elicited chemotactic activity through inhibition of CCR2: role of bilirubin and carbon monoxide generated by the enzyme. , 2003, Antioxidants & redox signaling.

[156]  N. Bouck,et al.  Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas , 2003, Nature Medicine.

[157]  L. Horstman,et al.  High levels of circulating endothelial microparticles in patients with acute coronary syndromes. , 2003, American heart journal.

[158]  Solomon H. Snyder,et al.  Biliverdin reductase: A major physiologic cytoprotectant , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[159]  T. Iwasaka,et al.  Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus , 2002, Diabetologia.

[160]  D. Levy,et al.  Total serum bilirubin and risk of cardiovascular disease in the Framingham offspring study. , 2001, The American journal of cardiology.

[161]  L. Fried,et al.  Frailty in older adults: evidence for a phenotype. , 2001, The journals of gerontology. Series A, Biological sciences and medical sciences.

[162]  T. Iwasaka,et al.  State-of-the-Art Review : Effect of Sarpogrelate Hydrochloride on Platelet-Derived Microparticles and Various Soluble Adhesion Molecules in Diabetes Mellitus , 2000 .

[163]  H. Schwertner,et al.  Comparison of various lipid, lipoprotein, and bilirubin combinations as risk factors for predicting coronary artery disease. , 2000, Atherosclerosis.

[164]  W. Benedict,et al.  Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. , 1999, Science.

[165]  A. Lusis,et al.  Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL. , 1997, The Journal of clinical investigation.

[166]  I. Rodriguez,et al.  Organization, evolutionary conservation, expression and unusual Alu density of the human gene for pigment epithelium-derived factor, a unique neurotrophic serpin. , 1996, Molecular vision.

[167]  J. Chan,et al.  Serum Bilirubin and Cardiovascular Risk Factors in a Chinese Population , 1996, Journal of cardiovascular risk.

[168]  S. Hunt,et al.  Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. , 1996, Arteriosclerosis, thrombosis, and vascular biology.

[169]  D Lindhout,et al.  The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. , 1995, The New England journal of medicine.

[170]  P. Whincup,et al.  Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men , 1995, BMJ.

[171]  D. Stump,et al.  The hepatocellular uptake of free fatty acids is selectively preserved during starvation. , 1994, Gastroenterology.

[172]  B. Ames,et al.  Bilirubin is an antioxidant of possible physiological importance. , 1987, Science.

[173]  J. Waterlow.  Classification and definition of protein-calorie malnutrition. , 1972, British medical journal.

[174]  R. Schmid,et al.  Metabolic regulation of heme catabolism and bilirubin production. I. Hormonal control of hepatic heme oxygenase activity. , 1972, The Journal of clinical investigation.

[175]  B. Felsher,et al.  The reciprocal relation between caloric intake and the degree of hyperbilirubinemia in Gilbert's syndrome. , 1970, The New England journal of medicine.

[176]  P. Wolf.  The Nature and Significance of Platelet Products in Human Plasma , 1967, British journal of haematology.

[177]  Hong-Kyu Kim,et al.  Higher serum bilirubin level as a protective factor for the development of diabetes in healthy Korean men: a 4 year retrospective longitudinal study. , 2014, Metabolism: clinical and experimental.

[178]  J. Meigs,et al.  Magnesium intake is inversely associated with coronary artery calcification: the Framingham Heart Study. , 2014, JACC. Cardiovascular imaging.

[179]  Kenneth Rockwood,et al.  Searching for an operational definition of frailty: a Delphi method based consensus statement: the frailty operative definition-consensus conference project. , 2013, The journals of gerontology. Series A, Biological sciences and medical sciences.

[180]  P. Bandosz,et al.  Inverse association of serum bilirubin with metabolic syndrome and insulin resistance in Polish population. , 2012, Przeglad epidemiologiczny.

[181]  Ming Chen,et al.  Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. , 2010, Atherosclerosis.

[182]  H. Schwertner,et al.  The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. , 2007, Advances in clinical chemistry.

[183]  T. Iwasaka,et al.  Effect of nifedipine on adiponectin in hypertensive patients with type 2 diabetes mellitus , 2007, Journal of Human Hypertension.

[184]  T. Iwasaka,et al.  Effect of valsartan on monocyte/endothelial cell activation markers and adiponectin in hypertensive patients with type 2 diabetes mellitus. , 2006, Thrombosis research.

[185]  J. Rosenstock.  Management of Type 2 Diabetes Mellitus in the Elderly , 2001, Drugs & aging.

[186]  P. Mathew.  The genetic basis of Gilbert's syndrome. , 1996, The New England journal of medicine.

[187]  K. Fung,et al.  Unconjugated bilirubin inhibits the oxidation of human low density lipoprotein better than Trolox. , 1994, Life sciences.